Droxia Related Clinical Trials
Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent MG [Recruiting]
Phase II Study of GIVINOSTAT (ITF2357) in Combination With Hydroxyurea in Polycythemia Vera [Recruiting]
Pharmacokinetics (PK) of Liquid Hydroxyurea in Pediatric Patients With Sickle Cell Anemia [Recruiting]
Inflammatory Response to Hydroxyurea Therapy in Sickle Cell Disease [Recruiting]
Transcranial Doppler (TCD) With Transfusions Changing to Hydroxyurea [Recruiting]
Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma [Completed]
Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET) [Recruiting]
Therapeutic Effect and Safety of Combined Hydroxyurea With Recombinant Human Erythropoietin. [Not yet recruiting]
Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM) [Active, not recruiting]
Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM) [Active, not recruiting]
Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease [Recruiting]
A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid Neoplasms [Recruiting]
Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE) [Recruiting]
Primary Thrombocythaemia 1 Trial [Recruiting]
Long Term Effects of Hydroxyurea Therapy in Children With Sickle Cell Disease [Recruiting]
Sleep Respiratory Disorders Evaluation in Sickle Cell Disease Children: Hydroxycarbamide Effect on Isolated Hypoxemia [Not yet recruiting]
Future of Spermatogenesis in Men With Sickle Cell Disease Medically Treated [Recruiting]
Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG [Recruiting]
Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG) [Recruiting]
Hydroxyurea With or Without Imatinib Mesylate in Treating Patients With Recurrent or Progressive Meningioma [Recruiting]
Hydroxyurea in Primary Progressive Multiple Sclerosis [Recruiting]
Ph II Imatinib Mesylate + Hydroxyurea in Treatment for Pts w Recurrent/Progressive Meningioma [Recruiting]
Evaluating the Safety of G-CSF Mobilization in Individuals With Beta Thalassemia Major [Recruiting]
Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors [Not yet recruiting]
The Safety and Effectiveness of Hydroxyurea and ddI Used Individually or Together in HIV-Infected Patients [Completed]
A Study of Anagrelide and Hydroxyurea in High-Risk Essential Thrombocythemia Patients [Recruiting]
Effectiveness of Early or Delayed Addition of Hydroxyurea to a Three-Drug Anti-HIV Drug Combination Including Didanosine, in Advanced HIV Patients Who Failed a First or Second Anti-HIV Triple-Drug Therapy [Completed]
Use of Hydroxyurea and Magnesium Pidolate for Treatment of Sickle Cell Disease [Completed]
Hydroxyurea in Young Children With Sickle Cell Anemia [Completed]
Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma [Recruiting]
Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma [Active, not recruiting]
Evaluation of Hydroxyurea Plus L-Arginine or Sildenafil to Treat Sickle Cell Anemia [Active, not recruiting]
Combination of Hydroxyurea and Verapamil for Refractory Meningiomas [Recruiting]
Hydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia) [Completed]
Hydroxyurea and Erythropoietin to Treat Sickle Cell Anemia [Recruiting]
Safety and Effectiveness of an Anti-HIV Drug Combination With and Without Hydroxyurea in Patients With Early HIV Infection [Terminated]
A Randomized, Placebo-Controlled Study of the Safety and Efficacy of Efavirenz, Didanosine, and Stavudine in Combination With or Without Hydroxyurea in Antiretroviral Naive or Experienced HIV-Infected Patients [Completed]
A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their Blood [Terminated]
Long Term Follow up in Sickle Cell Patients Treated by Hydroxyurea [Not yet recruiting]
Hydroxyurea in Treating Patients With Unresectable Benign Meningioma [Active, not recruiting]
Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa [Active, not recruiting]
Hydroxyurea to Prevent Stroke in Children With Sickle Cell Anemia and Elevated TCD Flow Velocity [Completed]
A Pilot Therapeutic Trial Using Hydroxyurea in Type I Spinal Muscular Atrophy [Recruiting]
A Pilot Therapeutic Trial Using Hydroxyurea in Type II and III Spinal Muscular Atrophy Patients [No longer recruiting]
A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and Neck [Recruiting]
Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) Tablets Versus Best Available Care: The RESPONSE Trial [Recruiting]
Hydroxyurea in Treating Patients With Epstein-Barr Virus-Associated Primary CNS Lymphoma and AIDS [Completed]
Safety and Effectiveness of Combining Hydroxyurea (HU) With Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected Adults [Completed]
A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection [Completed]
A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection [Completed]
Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma [Active, not recruiting]
Stroke With Transfusions Changing to Hydroxyurea (SWiTCH) [Recruiting]
Hydroxyurea Plus Combination Chemotherapy in Patients With Non-Small Cell Lung Cancer [Active, not recruiting]
A Pilot Theraputic Trial Using Hydroxyurea in Type I Spinal Muscular Atrophy Patients [Active, not recruiting]
A Pilot Theraputic Trial Using Hydroxyurea in Type II and Type III Spinal Muscular Atrophy Patients [Active, not recruiting]
Combination Drug Treatment of Pediatric HIV Infection [Completed]
Trial Comparing Two Protocols of re Irradiation in an Irradiated Area for Carcinoma of the Upper Aerodigestive Tract [Recruiting]
PHASE III TRIAL COMPARING, NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY VERSUS THE SAME NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY ASSOCIATED WITH DAILY HYDROXYUREA IN THE TREATMENT OF LOCALLY ADVANCED UNDIFFERENTIATED CARCINOMA NASOPHARYNGEAL TYPE. [Active, not recruiting]
Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer [Active, not recruiting]
Fluorouracil, Hydroxyurea, Cetuximab and Twice-Daily Intensity Radiation Therapy for Advanced Head and Neck Cancer [Recruiting]
Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia [Recruiting]
A Study of MKC-442 in Combination With Other Anti-HIV Drugs [Completed]
Hydroxyurea for Children and Young Adults With Sickle Cell Disease and Pulmonary Hypertension [Recruiting]
Safety and Effectiveness of a Combination Anti-HIV Drug Treatment [Completed]
Evaluating the Safety and Effectiveness of Hydroxyurea and Magnesium Pidolate to Treat People With Hemoglobin Sickle Cell Disease (CHAMPS) [Recruiting]
A Trial of Hydroxyurea in Spinal Muscular Atrophy [Recruiting]
Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET) [Recruiting]
Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage III-IV Head and Neck Cancer [Not yet recruiting]
Hydroxyurea for the Treatment of Patients With Sickle Cell Anemia [Active, not recruiting]
Radiation Therapy in Treating Patients With Glioblastoma [Completed]
Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes [Recruiting]
Adherence to Hydroxyurea in Children With Sickle Cell Anemia [Recruiting]
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases [Recruiting]
Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With Sickle Cell Anemia [Recruiting]
Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia [Active, not recruiting]
State Of The Art Functional Imaging In Sickle Cell Disease [Recruiting]
Pediatric Hydroxyurea in Sickle Cell Anemia (PED HUG) [Completed]
Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH) [Active, not recruiting]
Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer [Active, not recruiting]
The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined with MKC-442 in HIV-Infected Patients Who Have Not Had Success with Protease Inhibitors [Terminated]
A Study to Compare the Effectiveness of Different Anti-HIV Drug Regimens in Keeping Levels of HIV in the Blood as Low as Possible [Completed]
VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia [No longer recruiting]
A Study of TNFerade™ Biologic With Concomitant Radiotherapy, Fluorouracil, and Hydroxyurea (TNF-FHX) in Patients With Head and Neck Cancer [Recruiting]
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer [Completed]
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx [No longer recruiting]
Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer [Completed]
A Study Evaluating the Long-Term Safety of ICA-17043 in Sickle Cell Disease Patients With or Without Hydroxyurea Therapy [Recruiting]
The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success with Protease Inhibitors [Terminated]
A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia. [Completed]
A Study to Probe the Safety and Durability of Tenofovir and a Cell Cycle Agent to Maintain Viral Suppression [Completed]
Study to Determine the Safety and Efficacy of INCB018424 in Patients With Polycythemia Vera or Essential Thrombocythemia [Recruiting]
A Stratified Sickle Event Randomized Trial (ASSERT) [Suspended]
Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia [Recruiting]
A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection [Completed]
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia [No longer recruiting]
Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia [No longer recruiting]
Interferon-Alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia [Active, not recruiting]
Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer [No longer recruiting]
Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer [No longer recruiting]
Combination Chemotherapy and Interferon Alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer [No longer recruiting]
Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome [Active, not recruiting]
|
